T0	Participants 154 163	in China.
T1	Participants 318 352	non-erosive reflux disease (NERD).
T2	Participants 459 522	Patients who had complete symptom relief in the initial therapy
T3	Participants 1006 1207	398 patients were recruited in the initial therapy group, among whom 253 were included in on-demand therapy, with 127 patients in the hydrotalcite group and the remaining 126 in the esomeprazole group.
T4	Participants 1650 1667	for NERD patients